These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 894041)

  • 21. Reactivity of lymphocytes from normal persons on cultured tumor cells.
    Takasugi M; Mickey MR; Terasaki PI
    Cancer Res; 1973 Nov; 33(11):2898-902. PubMed ID: 4748446
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphocyte-mediated cytotoxicity on human tumor cells in vitro.
    Schwenke H; Schönfelder M
    Arch Geschwulstforsch; 1975; 45(8):802-9. PubMed ID: 1241765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of mononuclear effector cells in human blood.
    Hersey P; Edwards A; Edwards J
    Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Demonstration of immunoglobulin determinants on human lymphocytes].
    Storch H; Schwenke H; von Baehr R
    Allerg Immunol (Leipz); 1973; 19(2-4):219-22. PubMed ID: 4141865
    [No Abstract]   [Full Text] [Related]  

  • 25. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
    Perlmann P; Holm G; Stejskal V
    Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
    [No Abstract]   [Full Text] [Related]  

  • 27. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.
    Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H
    J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.
    Fauci AS; Balow JE; Pratt KR
    J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibody-dependent cytotoxicity of blood lymphocytes during rheumatoid polyarthritis].
    Sany J; Clot J; Freitas M; Charmasson E; Serre H
    Rev Rhum Mal Osteoartic; 1976 May; 43(5):333-8. PubMed ID: 1273483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six-year study of autografts of irradiated tumour adjuvant to mastectomy and radiotherapy for cancer of the breast.
    Anderson JM
    Panminerva Med; 1975; 17(5-6):179-81. PubMed ID: 1161315
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoimmunity in diseases of the thyroid, adrenals and gonads in man. Assessment of T, B and K cells in man.
    MacLennan IC
    Proc R Soc Med; 1975 Apr; 68(4):249-50. PubMed ID: 1081695
    [No Abstract]   [Full Text] [Related]  

  • 32. Fate of HL-A antigens and antibodies at the lymphocyte surface.
    Cullen SE; Bernoco D; Carbonara AO; Jacot-Guillarmod H; Trinchieri G; Ceppellini R
    Transplant Proc; 1973 Dec; 5(4):1835-47. PubMed ID: 4130085
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
    Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L
    Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of lymphocytes on the human breast cancer cell in vitro].
    Liu HC; Prigenzi LS; Pinotti JA
    AMB Rev Assoc Med Bras; 1978 Feb; 24(2):44-6. PubMed ID: 306636
    [No Abstract]   [Full Text] [Related]  

  • 35. Receptors for Fc and complement in human breast carcinoma.
    Turner DT; Connolly CE; Isaacson P; Turnbull AR
    Clin Oncol; 1978 Mar; 4(1):87-92. PubMed ID: 639380
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonspecific cytotoxic effects of antigen-transformed lymphocytes. Kinetics, cell-requirements and the role of recruitment.
    Butterworth AE
    Cell Immunol; 1973 Jun; 7(3):357-69. PubMed ID: 4718858
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours.
    Vose BM; Moore M
    Int J Cancer; 1979 Nov; 24(5):579-85. PubMed ID: 160895
    [No Abstract]   [Full Text] [Related]  

  • 38. Search for disease-related cytotoxicity in mammary tumor patients.
    Bakacs T; Klein E; Ljungström KG
    Cancer Lett; 1978 Apr; 4(4):191-7. PubMed ID: 206348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microcytotoxicity test results with human cells: why the controversy?
    Bean MA; Kodera Y; Akiyama M
    Isr J Med Sci; 1978 Jan; 14(1):162-76. PubMed ID: 632080
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures.
    Bakács T; Gergely P; Cornain S; Klein E
    Int J Cancer; 1977 Apr; 19(4):441-9. PubMed ID: 321366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.